share_log

Urovo Technology (SZSE:300531) Shareholders Are up 24% This Past Week, but Still in the Red Over the Last Five Years

Urovo Technology (SZSE:300531) Shareholders Are up 24% This Past Week, but Still in the Red Over the Last Five Years

優博訊(SZSE:300531)股東上週增長了24%,但在過去五年中仍處於虧損狀態。
Simply Wall St ·  18:55

Urovo Technology Co., Ltd. (SZSE:300531) shareholders should be happy to see the share price up 24% in the last week. But if you look at the last five years the returns have not been good. After all, the share price is down 34% in that time, significantly under-performing the market.

優羅沃科技股份有限公司(深圳證券交易所代碼:300531)的股東應該很高興看到上週股價上漲24%。但是,如果你看看過去的五年,回報並不理想。畢竟,當時股價下跌了34%,表現大大低於市場。

On a more encouraging note the company has added CN¥706m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.

更令人鼓舞的是,該公司的市值在過去的7天內就增加了70600萬元人民幣,因此,讓我們看看我們能否確定導致股東五年虧損的原因。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

儘管一些人繼續教導高效市場假說,但事實證明,市場是反應過度的動態系統,投資者並不總是理性的。考慮市場對公司的看法發生了怎樣的變化的一種不完美但簡單的方法是將每股收益(EPS)的變化與股價走勢進行比較。

Over five years Urovo Technology's earnings per share dropped significantly, falling to a loss, with the share price also lower. The recent extraordinary items contributed to this situation. Since the company has fallen to a loss making position, it's hard to compare the change in EPS with the share price change. However, we can say we'd expect to see a falling share price in this scenario.

在過去的五年中,Urovo Technology的每股收益大幅下降,跌至虧損,股價也有所下降。最近的特殊物品助長了這種情況。由於該公司已跌至虧損狀態,因此很難將每股收益的變化與股價的變化進行比較。但是,我們可以說,在這種情況下,我們預計股價將下跌。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨着時間的推移)如下圖所示(點擊查看確切數字)。

big
SZSE:300531 Earnings Per Share Growth July 25th 2024
深圳證券交易所:300531 每股收益增長 2024 年 7 月 25 日

This free interactive report on Urovo Technology's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

如果你想進一步調查該股,這份關於Urovo Technology收益、收入和現金流的免費互動報告是一個很好的起點。

A Different Perspective

不同的視角

Although it hurts that Urovo Technology returned a loss of 16% in the last twelve months, the broader market was actually worse, returning a loss of 19%. Given the total loss of 6% per year over five years, it seems returns have deteriorated in the last twelve months. While some investors do well specializing in buying companies that are struggling (but nonetheless undervalued), don't forget that Buffett said that 'turnarounds seldom turn'. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for Urovo Technology that you should be aware of before investing here.

儘管Urovo Technology在過去十二個月中回報了16%的虧損令人痛心,但整個市場實際上更糟,虧損了19%。鑑於五年內每年的總損失爲6%,在過去的十二個月中,回報似乎有所惡化。儘管一些投資者在專門收購陷入困境(但仍被低估)的公司方面表現良好,但不要忘記巴菲特說過 “轉機很少會轉機”。我發現將長期股價視爲業務績效的代表非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。例如,我們發現了Urovo Technology的1個警告信號,在這裏投資之前,您應該注意這一點。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

如果你想看看另一家公司——一家財務狀況可能優異的公司——那麼千萬不要錯過這份已經證明自己可以增加收益的公司的免費名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件至 editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論